Bethesda, MD - The 2015 FASEB Science Research Conference Melatonin Biology: Actions and Therapeutics will focus on the role of melatonin and its analogues as potential drugs in the treatment of sleep and circadian disorders, insomnia, cancer, immune dysfunction, inflammatory processes, and neurodegenerative disease. The information presented will range from the continuing identification of a new role for melatonin in supporting health to the understanding of melatonin receptors in the diagnosis and prevention of human disease. This fourth international conference is the only one of its kind to bring together investigators from around the world with an interest in studying melatonin and its biology for the purpose of developing novel therapeutic agents.
FASEB has announced a total of 34 Science Research Conferences (SRC) in 2015. Registration opens January 20, 2015. For more information about an SRC, view preliminary programs, or find a listing of all our 2015 SRCs, please visit http://www.
Since 1982, FASEB SRC has offered a continuing series of inter-disciplinary exchanges that are recognized as a valuable complement to the highly successful society meetings. Divided into small groups, scientists from around the world meet intimately and without distractions to explore new approaches to those research areas undergoing rapid scientific changes.
FASEB is composed of 27 societies with more than 120,000 members, making it the largest coalition of biomedical research associations in the United States. Our mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.
Federation of American Societies for Experimental Biology
9650 Rockville Pike, Bethesda, MD 20814-3998
Contact: Kristen Hagy, CMP
Office of Scientific Meetings & Conferences
MELATONIN BIOLOGY: ACTIONS AND THERAPEUTICS
Date: July 19-24, 2015, Lisbon, Portugal
Organizer Name: James Olcese, Nava Zisapel